These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 38140105)

  • 1. Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives.
    Zhang W; Zhang Q; Cao Z; Zheng L; Hu W
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data.
    Claassen K; Thelen K; Coboeken K; Gaub T; Lippert J; Allegaert K; Willmann S
    Curr Pharm Des; 2015; 21(39):5688-98. PubMed ID: 26323410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates.
    Kovar L; Schräpel C; Selzer D; Kohl Y; Bals R; Schwab M; Lehr T
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial Effect.
    Neeli H; Hanna N; Abduljalil K; Cusumano J; Taft DR
    J Clin Pharmacol; 2021 Oct; 61(10):1356-1365. PubMed ID: 33945155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pragmatic physiologically-based pharmacokinetic modeling to support clinical implementation of optimized gentamicin dosing in term neonates and infants: proof-of-concept.
    de Hoop-Sommen MA; van der Heijden JEM; Freriksen JJM; Greupink R; de Wildt SN
    Front Pediatr; 2023; 11():1288376. PubMed ID: 38078320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients.
    Kovar L; Weber A; Zemlin M; Kohl Y; Bals R; Meibohm B; Selzer D; Lehr T
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32977559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute.
    Smits A; De Cock P; Vermeulen A; Allegaert K
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):25-34. PubMed ID: 30554542
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologically-Based Pharmacokinetic Modeling and Dosing Optimization of Cefotaxime in Preterm and Term Neonates.
    Li Q; Guan Y; Xia C; Wu L; Zhang H; Wang Y
    J Pharm Sci; 2024 Mar; ():. PubMed ID: 38460573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK modeling and simulation in drug research and development.
    Zhuang X; Lu C
    Acta Pharm Sin B; 2016 Sep; 6(5):430-440. PubMed ID: 27909650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBPK in Preterm and Term Neonates: A Review.
    Michelet R; Bocxlaer JV; Vermeulen A
    Curr Pharm Des; 2017; 23(38):5943-5954. PubMed ID: 28990526
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang CX; Arnold SLM
    Drug Metab Dispos; 2023 Sep; ():. PubMed ID: 37714715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.
    Duan P; Fisher JW; Yoshida K; Zhang L; Burckart GJ; Wang J
    Clin Pharmacokinet; 2017 Apr; 56(4):383-394. PubMed ID: 27596256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview.
    Jia Q; He Q; Yao L; Li M; Lin J; Tang Z; Zhu X; Xiang X
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
    van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients.
    Heimbach T; Lin W; Hourcade-Potelleret F; Tian X; Combes FP; Horvath N; He H
    J Pharm Sci; 2019 Jun; 108(6):2191-2198. PubMed ID: 30721710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates.
    Allegaert K; Abbasi MY; Annaert P; Olafuyi O
    Expert Opin Drug Metab Toxicol; 2022 May; 18(5):301-312. PubMed ID: 35796504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms.
    El-Khateeb E; Burkhill S; Murby S; Amirat H; Rostami-Hodjegan A; Ahmad A
    Biopharm Drug Dispos; 2021 Apr; 42(4):107-117. PubMed ID: 33325034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.
    Chaphekar N; Dodeja P; Shaik IH; Caritis S; Venkataramanan R
    Front Pediatr; 2021; 9():733823. PubMed ID: 34805038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity.
    Gaohua L; Miao X; Dou L
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1103-1124. PubMed ID: 34253134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.